IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis-Reference-Cited by-同舟云学术

IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis

Published:2017-07 Issue:1 Volume:140 Page:109-120
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Johnston Andrew^ORCID,Xing Xianying,Wolterink Liza,Barnes Drew H.,Yin ZhiQiang,Reingold Laura,Kahlenberg J. Michelle,Harms Paul W.,Gudjonsson Johann E.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Psoriasis;Gudjonsson,2012

2. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis;Hussain;J Allergy Clin Immunol,2015

3. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis;Onoufriadis;Am J Hum Genet,2011

4. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes;Setta-Kaffetzi;J Invest Dermatol,2013

5. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist;Sugiura;J Invest Dermatol,2013

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world use of spesolimab for the treatment of generalized pustular psoriasis: reports from four cases;Journal of Dermatology for Physician Assistants;2024-08-21

2. Epidermal proteomics demonstrates Elafin as a psoriasis‐specific biomarker and highlights increased anti‐inflammatory activity around psoriatic plaques;Journal of the European Academy of Dermatology and Venereology;2024-08-19

3. RNA-binding proteins potentially regulate alternative splicing of immune/inflammatory-associated genes during the progression of generalized pustular psoriasis;Archives of Dermatological Research;2024-08-19

4. Clinical efficacy and safety of secukinumab in the treatment of generalized pustular psoriasis in the pediatric population: a systematic review of the literature;Frontiers in Medicine;2024-08-09

5. Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval;Frontiers in Immunology;2024-07-22